Evaluating the Implementation of Products to Help Learning Health Systems Use Findings from AHRQ Evidence Reports

ICR 202004-0935-003

OMB: 0935-0251

Federal Form Document

ICR Details
0935-0251 202004-0935-003
Active
HHS/AHRQ
Evaluating the Implementation of Products to Help Learning Health Systems Use Findings from AHRQ Evidence Reports
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 07/21/2020
Retrieve Notice of Action (NOA) 04/16/2020
AHRQ will ensure that respondents receive the information on the PRA burden statement, including where to address comments on the estimate of the burden and suggestions for reducing burden.
  Inventory as of this Action Requested Previously Approved
07/31/2023 36 Months From Approved
308 0 0
216 0 0
0 0 0

AHRQ’s Evidence-based Practice Center (EPC) Program has 20 years of experience in synthesizing research to inform evidence-based health care practice, delivery, policies, and research. The AHRQ EPC program is committed to partnering with organizations to make sure its evidence reports can be used in practice. Historically, most of its evidence reports have been used by clinical professional organizations to support the development of clinical practice guidelines or Federal agencies to inform their program planning and research priorities. To improve uptake and relevance of the AHRQ EPC’s evidence reports, specifically for health systems, AHRQ has funded the American Institutes for Research (AIR) to convene a panel of learning health systems (LHSs) to provide feedback to the AHRQ EPC program in developing and disseminating evidence reports that can be used to improve the quality and effectiveness of patient care. Even if an EPC evidence report topic addresses LHS-specific evidence needs, the density of the information in an evidence report may preclude its easy review by busy LHS leaders and decisionmakers. AHRQ understands that to facilitate use by LHSs, complex evidence reports must be translated into a format that promotes LHS evidence-based decision making and can be contextualized within each LHSs’ own system-generated evidence. Such translational products, for the purposes of this supporting statement, are referred to simply as “products”. The purpose of this information collection is to support a process evaluation of decisionmaking around, and use and implementation of, two such products into LHS decision processes, workflows, and clinical care. The evaluation has the following goals: 1. Document how LHSs prioritize filling evidence gaps, make decisions about using evidence, and implement tools to support and promote evidence use in clinical care. 2. Assess the contextual factors that may influence implementation success; associated implementation resources, barriers and facilitators; and satisfaction of LHS leaders and clinical staff. 3. Provide the AHRQ EPC program with necessary insights about the perspectives, needs, and preferences of LHS leaders and clinical staff as related to decisions and implementation of products into practice.

US Code: 42 USC 299 Name of Law: Healthcare Research and Quality Act of 1999
  
None

Not associated with rulemaking

  85 FR 6194 02/04/2020
85 FR 20497 04/13/2020
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 308 0 0 308 0 0
Annual Time Burden (Hours) 216 0 0 216 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new data collection.

$230,615
No
    Yes
    No
No
No
No
No
Erwin Brown 301 427-1652 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
04/16/2020


© 2024 OMB.report | Privacy Policy